title: [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"].
authors.forename: J
authors.initials: J
authors.lastname: Hanzlik
authors.forename: A
authors.initials: A
authors.lastname: Wojnicz
authors.forename: I
authors.initials: I
authors.lastname: Wolański
authors.forename: J
authors.initials: J
authors.lastname: Grzywnowicz
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002764:Cholecystitis / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011044:Poland; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012294:Rifamycins / Q000008:administration & dosage*; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D012294:Rifamycins; C023808:rifamycin SV
vernacular_title: Ocena kliniczna preparatu rifamycin SV w ampułkach à 250 i 500 mg produkcji Tarchomińskich Zakładów Farmaceutycznych "Polfa".